Genitourinary Syndrome of Menopause (GSM): Why We No Longer Use Lasers for Vaginal Rejuvenation

Modern approaches to dryness, bladder control & intimacy

Most women have never heard the term genitourinary syndrome of menopause, but nearly all of them know the symptoms. Vaginal dryness. Pain during sex. Sudden bladder urgency. Leakage. These aren’t minor inconveniences, and they’re not inevitable. They’re signs of GSM, a condition rooted in estrogen loss that affects the vagina, bladder, urethra, and surrounding tissues — and one that responds well to today’s non-surgical treatments.

At RegenCen, we’ve spent years refining how we treat GSM. That evolution includes moving away from laser-based devices like CO₂RE Intima and Mona Lisa Touch in favor of MorpheusV — a radiofrequency microneedling technology that reaches deeper tissue layers, produces more durable results, and addresses all three of the biggest GSM complaints in a single treatment. Here’s what you should know.

Some of the most common — and most under-discussed — issues women experience after menopause involve vaginal and urinary health. Vaginal dryness, pain with intercourse, loss of sexual enjoyment, along with bladder urgency, frequency, and even occasional leakage, are all extremely common. Over half of women in their 60s have urinary symptoms, and in women who aren’t on hormone replacement therapy, vaginal sexual dysfunction affects over 80%. That can make intimacy difficult, unpleasant or even impossible.

At the root of these symptoms is the loss of hormone signaling to tissues that are uniquely dependent on estrogen. For many years, doctors called it vaginal atrophy, but that term turned out to be far too narrow. We now use the term Genitourinary Syndrome of Menopause (GSM) because it more accurately reflects what is really happening to everything “down there.” Estrogen supports not just the vaginal lining, but the bladder, urethra, pelvic floor musculature, connective tissue, nerves, and even the external vulvar structures. When estrogen disappears after menopause, that’s a powerful signal for those tissues to age — but quietly. Because it’s gradual, many women don’t immediately connect these changes to menopause. It may take five, ten, or even more years before the cumulative effects become disruptive to daily comfort, confidence, or intimacy.

At this point, many women assume the only answer is hormone replacement — and yes, restoring hormone signaling is a critical foundation. But by the time someone reaches their 60s, hormone deficiency has caused real structural and functional changes in the tissues themselves. Hormones alone will partially reverse the process, but they don’t always fully restore tissue quality, elasticity, or nerve responsiveness. This is where newer, non-surgical technologies have changed what’s possible.

MorpheusV is one of the most advanced options available today. It uses radiofrequency-assisted microneedling — technology that has been used for years on the face and body to improve skin quality, firmness, and collagen structure — adapted specifically for vaginal and pelvic tissues. Many women don’t realize that vaginal tissue is essentially a specialized extension of skin. Vaginal “skin” structure and function may be unique, but it responds to regenerative stimulation in very similar ways. By delivering controlled energy at precise depths, MorpheusV stimulates collagen remodeling, improves tissue elasticity, enhances blood flow, and helps normalize nerve signaling in the vaginal and peri-urethral tissues — the same regenerative principles we’ve relied on for years in facial and body rejuvenation. In short, the vagina goes back to its old self.

MorpheusV works best when combined with optimized hormone therapy, which may be vaginal or systemic. The results can be dramatic. Women commonly report major improvements in vaginal comfort, lubrication, and sexual enjoyment within weeks or months. Just as importantly, many experience reduced urinary urgency, frequency, and leakage as pelvic tissues and nerve responses begin to function more normally again. Patient satisfaction rates exceed 90%, which is remarkably high in any area of medicine — and all without surgery!

Perhaps the most powerful outcome, though, is less measurable: the relief of not having to think about these symptoms all day long. Not bracing for pain with sex. Not quietly accepting changes that erode confidence and enjoyment of life. These issues may be common — but they are not something women simply have to live with. And today, addressing them does not require surgery. Highly effective, well-tolerated, non-surgical options exist, and for many women, they can be truly life-changing.

Laser Treatments vs. MorpheusV: What’s the Difference?

Laser-based vaginal treatments like CO₂RE Intima and Mona Lisa Touch were among the first options for vaginal rejuvenation, and while they can offer mild, short-term improvement for some women, their effects are limited. Lasers primarily work at the surface of the tissue and don’t reliably reach the deeper layers responsible for strength, elasticity, blood flow, and nerve function — especially in women with more advanced changes from menopause.

MorpheusV works differently. It uses radiofrequency energy delivered through tiny microneedles to reach deeper, more meaningful tissue layers, stimulating collagen remodeling, improving tissue quality, and helping normalize nerve signaling. In our experience, MorpheusV produces more noticeable, longer-lasting improvements in comfort, intimacy, and urinary symptoms. That’s why we no longer use laser-based vaginal devices in our practice and instead rely on MorpheusV as our preferred non-surgical option.

Take our pelvic floor quiz at regencen.com/quiz.

📍 You can find RegenCen in:

Or click here to book online at any RegenCen location.